Consistently, our experiments validated that ATP6AP1L overexpression inhibited breast cancer cell proliferation and migration, suggesting that ATP6AP1L might play a tumor-suppressor role in breast cancer progression. The gene discussed is ATP6AP1L; the disease is breast cancer.